PSS WORLD MEDICAL INC
NT 11-K, 2000-09-27
MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES
Previous: LA JOLLA PHARMACEUTICAL CO, 424B3, 2000-09-27
Next: NORTHFIELD LABORATORIES INC /DE/, DFAN14A, 2000-09-27



                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                   FORM 12b-25

                                             Commission File Number    0-23832
                                                                     -----------

                           NOTIFICATION OF LATE FILING

      (Check One): [ ] Form 10-K [X] Form 11-K [ ] Form 20-F [ ] Form 10-Q
 [ ] Form N-SAR

 For Period Ended:          For the Fiscal Year ended March 31, 2000
                   -------------------------------------------------------------

[  ] Transition Report on Form 10-K    [  ] Transition Report on Form 10-Q
[  ] Transition Report on Form 20-F    [  ] Transition Report on Form N-SAR
[  ] Transition Report on Form 11-K

For the Transition Period Ended:
                                ------------------------------------------------

    Read attached instruction sheet before preparing form. Please print or type.

         Nothing in this form shall be  construed  to imply that the  Commission
has verified any information contained herein.

         If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
                                                       -------------------------
                         Part I. Registrant Information

Full name of registrant: PSS World Medical, Inc. Employee Stock Ownership and
Savings Plan
Former name if applicable:    N/A
Address of principal executive office (Street and number): 4345 Southpoint Blvd.
City, State and Zip Code:     Jacksonville, Florida 32216

                        Part II. Rule 12b-25 (b) and (c)

         If the subject report could not be filed without unreasonable effort or
expense  and  the  registrant  seeks  relief  pursuant  to Rule  12b-25(b),  the
following should be completed. (Check appropriate box.)

[ X ] (a) The reasons described in reasonable detail in Part III of this form
          could not be eliminated without unreasonable effort or expense;

[ X ] (b) The  subject  annual  report,  semi-annual  report,  transition report
          on Form 10-K,  20-F, 11-K or Form N-SAR, or portion thereof will be
          filed on or before the 15th calendar day  following  the  prescribed
          due date; or the subject  quarterly report or transition report on
          Form 10-Q, or portion  thereof will be filed on or before the fifth
          calendar day following the prescribed due date; and

[   ] (c) The accountant's statement or other exhibit required by Rule
          12(b)-25(c) has been attached if applicable.

<PAGE>



                               Part III. Narrative

         State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F,
10-Q,  N-SAR or the transition  report portion thereof could not be filed within
the prescribed time period. (Attach extra sheets if needed.)


                  We are in the process of obtaining  certain documents from the
         recordkeeper  and  trustee  related  to the  PSS  World  Medical,  Inc.
         Employee Stock Ownership and Savings Plan.  Therefore,  we will be late
         in filing our annual report on Form 11-K for the period ended March 31,
         2000.  We plan to file our  annual  report on Form 11-K for the  period
         ended March 31, 2000 in less than 15 calendar  days after the  original
         due date for such filing  pursuant to Part II (b) hereof.  We could not
         eliminate  the factors  stated above  without  unreasonable  effort and
         expense.


                           Part IV. Other Information

(1) Name and telephone number of person to contact in regard to this
    notification

    David A. Smith (Chief Financial Officer)               (904) 332-3000
--------------------------------------------------------------------------------
              (Name)                               (Area code)(Telephone number)

         (2) Have all other periodic  reports required under Section 13 or 15(d)
of the Securities  Exchange Act of 1934 or Section 30 of the Investment  Company
Act of 1940 during the  preceding 12 months or for such shorter  period that the
registrant was required to file such report(s) been filed?  If the answer is no,
identify report(s).
                                                             [X]  Yes  [   ]  No

         (3) Is it  anticipated  that  any  significant  change  in  results  of
operations  from the  corresponding  period  for the last  fiscal  year  will be
reflected by the  earnings  statements  to be included in the subject  report or
portion thereof?
                                                             [   ]  Yes  [X]  No

         If  so:  attach  an  explanation  of  the  anticipated   change,   both
narratively and  quantitatively,  and, if  appropriate,  state the reasons why a
reasonable estimate of the results cannot be made.

                             PSS World Medical, Inc.
          ------------------------------------------------------------
                  (Name of registrant as specified in charter)

Has  caused  this  notification  to be signed on its  behalf by the  undersigned
thereunto duly authorized.




Date:   September 27, 2000              By:    /s/ David A. Smith
                                           -------------------------------------
                                                   David A. Smith
                                                   Chief Financial Officer




                                       2
<PAGE>






                                 ALSTON&BIRD LLP

                               One Atlantic Center
                           1201 West Peachtree Street
                           Atlanta, Georgia 30309-3424

                                  404-881-7000
                                Fax: 404-881-7777

                          601 Pennsylvania Avenue, N.W.
                            North Building, Suite 250
                           Washington, D.C. 20004-2601


Kimberly A. Knight                                     Direct Dial: 404-881-7593


                               September 27, 2000

Via EDGAR

Securities and Exchange Commission
Judiciary Plaza, 450 Fifth Street, N.W.Washington, D.C.  20549

               Re:   PSS World Medical, Inc. Employee Stock Ownership and
                     Savings Plan (the "Plan")
               Form 12b-25 Filing for Late Form 11-K
               Commission File No. 0-23832

Ladies and Gentlemen:

         The  Plan  hereby  is  filing  with  the  Commission,  pursuant  to the
Securities Exchange Act of 1934, as amended, a Form 12b-25 for the Plan's Annual
Report on Form 11-K (the "Form  11-K") for the year ended  March 31,  2000.  The
Company  plans to file the Form 11-K with the  Commission  within 15 days of its
original due date.

         If you have any questions  concerning the foregoing  materials,  please
contact the undersigned at the above direct-dial number.

                                                     Sincerely yours,

                                                     /s/ Kimberly A. Knight

                                                     Kimberly A. Knight




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission